Rap1 Activators are Novel Anti-Angiogenic Agents

Authors

Robert C. Doebele, University of ColoradoFollow
Mark W. Lingen, University of ChicagoFollow
Jacques E. Nör, University of Michigan School of DentistryFollow
Diane June Rodi, Argonne National LaboratoryFollow
Jia Hong, University of Chicago
Benjamin David Zeitlin, University of the PacificFollow
Wei-Jen Tang, University of ChicagoFollow
Marsha Rich Rosner, University of ChicagoFollow

ORCiD

Dr. Benjamin D. Zeitlin: 0000-0003-0110-0188

Department

Biomedical Sciences

Document Type

Poster

Conference Title

97th AACR Annual Meeting: 2006

Organization

American Association for Cancer Research

Location

Washington, D.C.

Conference Dates

April 1-5, 2006

Date of Presentation

4-1-2006

Comments

Conference Program: http://www.aacr.org/Documents/AM2006_Program.pdf

Recommended Citation

Doebele, R. C., Lingen, M. W., Nör, J. E., Rodi, D. J., Hong, J., Zeitlin, B. D., Tang, W., & Rosner, M. R. (2006). Rap1 Activators are Novel Anti-Angiogenic Agents. Paper presented at 97th AACR Annual Meeting: 2006 in Washington, D.C..
https://scholarlycommons.pacific.edu/dugoni-facpres/90